![Donato Spota](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Donato Spota served as the Chief Financial Officer at Basilea Pharmaceutica AG from 2013 to 2019.
He then joined Hansa Biopharma AB as the Chief Financial Officer & Senior Vice President in 2019, a position he held until 2024.
Mr. Spota holds an MBA from Hochschule für Wirtschaft & Umwelt Nürtingen-Geislingen.
Antiguos cargos conocidos de Donato Spota.
| Empresas | Cargo | Fin |
|---|---|---|
| HANSA BIOPHARMA AB | Director Financiero/CFO | 28/02/2024 |
| BASILEA PHARMACEUTICA AG | Director Financiero/CFO | 10/04/2019 |
Formación de Donato Spota.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
33
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Basilea Pharmaceutica AG
 Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Hochschule für Wirtschaft & Umwelt Nürtingen-Geislingen
 Hochschule für Wirtschaft & Umwelt Nürtingen-Geislingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
- Bolsa de valores
- Insiders
- Donato Spota
